Edward R. Melnick, M.D., M.H.S., principal investigator; Molly M. Jeffery, Ph.D., site principal investigator |
EMBED: Pragmatic Trial of User-Centered Clinical Decision Support to Implement Emergency Department-Initiated Buprenorphine for Opioid Use Disorder (UH3 DA047003-02) |
National Institute on Drug Abuse |
04/2019-8/2023 |
Corita R. Grudzen, M.D., principal investigator; Fernanda Bellolio, M.D., M.S., site principal investigator |
PRIM-ER: Primary Palliative Care for Emergency Medicine (UH3 AT09844-02) |
National Center for Complementary and Integrative Health |
07/2019-07/2023 |
Kalyan S. Pasupathy, Ph.D., principal investigator; Fernanda Bellolio, M.D., M.S., co-investigator |
IDEA-LL: Improving Diagnosis in Emergency and Acute Care-Learning Laboratory (R18HS26622-2) |
Agency for Healthcare Research and Quality |
07/2018-06/2023 |
W. Michael Hooten, M.D., principal investigator; Molly M. Jeffery, Ph.D., co-investigator |
Unintended Prolonged Opioid Use (U01 TR002743-01) |
National Center for Advancing Translational Sciences |
03/2019-02/2023 |
Sundeep Khosla, M.D., principal investigator; Molly M. Jeffery, Ph.D., co-investigator |
Center for Clinical and Translational Science (CCaTS) Administrative Supplement: Decision Support for Pain Management in Primary Care |
National Center for Advancing Translational Sciences |
09/18/2017-06/30/2022 |
Nathan W. Cummins, M.D., principal investigator; Fernanda Bellolio, M.D., M.S., site co-principal investigator |
Angiotensin Receptor Blockers for Novel SARS-CoV-2: A Multicenter Randomized Control Trial (P008672201) |
Minnesota Partnership for Biotechnology and Medical Genomics |
04/15/2020-04/14/2022 |
Pinar Karaca-Mandic, Ph.D., principal investigator; Molly M. Jeffery, Ph.D., site principal investigator |
Biosimilars: Policy, Insurance and Implications for Cancer Patients (RSGI-17-154-01) |
American Cancer Society |
01/2018-12/2021 |
Pinar Karaca-Mandic, Ph.D., principal investigator; Molly M. Jeffery, Ph.D., co-investigator |
Medical Reversals: Deimplementing Ineffective and Unsafe Treatments (R01 0HS25164-3) |
Agency for Healthcare Research and Quality |
09/2017-08/2021 |
Molly M. Jeffery, Ph.D., principal investigator |
Acute Pain Pathways |
Food and Drug Administration |
2019-2021 |
Fernanda Bellolio, M.D. M.S., principal investigator |
REDEEM: Recognizing Delirium in Emergency Medicine |
Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery |
06/2019-06/2020 |
Matthew A. Rank, M.D., principal investigator; Molly M. Jeffery, Ph.D., site principal investigator |
Step-Down of Asthma Biologics in Real-World Practice Settings (R21 HL140287-02) |
National Heart, Lung, and Blood Institute |
08/2018-06/2020 |
Robin E. Bryde, M.D., co-principal investigator; Brian P. Shapiro, M.D., co-principal investigator; Andrea C. Sharp, M.D., co-investigator |
Characterizing Left and Right Ventricular Function in Relation to Exercise Capacity in Breast Cancer Survivors |
Mayo Clinic Department of Cardiovascular Diseases |
01/2020-12/2020 |
Johnathan (John) M. Sheele, M.D., M.H.S., M.P.H., principal investigator |
Research Accelerator for Clinicians Engaged in Research Program (RACER) |
Mayo Clinic |
01/2020-12/2020 |
Molly M. Jeffery, Ph.D., principal investigator |
Harms Associated With Unsafe Prescribing of Opioids Subject to REMS |
U.S. Food and Drug Administration |
2019-2020 |
Michael P. Boniface, M.D., principal investigator |
Patient-Centered Outcomes Following Implementation of a Point-of-Care Ultrasound Curriculum for Internal Medicine Residents: An Exploratory Study |
Endowment for Education Research Award |
01/2019-12/2019 |
Andrea C. Sharp, M.D., principal investigator |
Research Accelerator for Clinicians Engaged in Research Program (RACER) |
Mayo Clinic |
01/2019-12/2019 |
Molly M. Jeffery, Ph.D., principal investigator |
Addressing Unsafe Prescribing of Opioids Subject to REMS: Prevalence |
Food and Drug Administration |
2018-2019 |
Laura E. Walker, M.D., principal investigator |
Shared Decision-Making to Improve Goals of Care Discussions in Elderly Emergency Department Patients |
Emergency Medicine Foundation |
2017-2018 |
Jana L. Anderson, M.D., principal investigator |
Shared Decision-Making in Parents of Children With Acute Otitis Media: The Acute Otitis Media Choice Trial (FP00087437) |
Emergency Medicine Foundation |
07/01/2016-12/31/2018 |
Pinar Karaca-Mandic, Ph.D., principal investigator; Molly M. Jeffery, Ph.D., co-investigator |
Diffusion of Clinical Evidence into Practice: Physician Networks, Delivery Organizations, and Markets (R56 HL130496-01) |
National Heart, Lung and Blood Institute |
09/2016-08/2018 |
J. Donald Easton, M.D., principal investigator; Fernanda Bellolio, M.D., M.S., site principal investigator |
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial (U01NS062835-06) |
National Institute of Neurological Disorders and Stroke |
05/01/2017-04/30/2018 |
Casey M. Clements, M.D., Ph.D., site principal investigator |
Emergency Department Sepsis Program Sample Repository: Biomarker Discovery for Prognosis and Risk Stratification of Undifferentiated Sepsis Patients Presenting to the Emergency Department |
The Antioch Foundation |
04/2013-03/2016 |
Casey M. Clements, M.D., Ph.D., principal investigator |
Fluoroquinolone Resistance and Patient Outcomes in Patients with E. Coli |
The Antioch Foundation |
02/2014-02/2016 |
Scott M. Silvers, M.D., principal investigator |
A Randomised, Double-Blind, Parallel-Group Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Desmoteplase in Subjects With Acute Ischemic Stroke |
Lundbeck |
2012-2014 |
Michael M. Mohseni, M.D., principal investigator |
Runners' Science |
Mayo Clinic |
2008-2011 |